Vimarsana
Biggest News Aggregation in the World

Feng Wang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Feng Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Feng Wang Today - Breaking & Trending Today

HUTCHMED Highlights Presentations at the 2024 ASCO Annual Meeting - Vimarsana News

HUTCHMED Highlights Presentations at the 2024 ASCO Annual Meeting

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 23, 2024 -- HUTCHMED Limited today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be...

HUTCHMED Presentations at 2024 ASCO Annual Meeting | Company Announcement - Vimarsana News

HUTCHMED Presentations at 2024 ASCO Annual Meeting | Company Announcement

Investegate announcements from HUTCHMED Presentations at 2024 ASCO Annual Meeting

National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma - Vimarsana News

National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma

/PRNewswire/ -- Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) announced that the company's lead innovative...

Berkeley Lab Scientists Invent Novel Microdevice Array for Energy Efficient Optical Computing - Vimarsana News

Berkeley Lab Scientists Invent Novel Microdevice Array for Energy Efficient Optical Computing

Scientists at Lawrence Berkeley National Laboratory have developed a breakthrough technology that could greatly develop the field of optical computing and devic

PET/MRI accurately classifies prostate cancer - Vimarsana News

PET/MRI accurately classifies prostate cancer

PET/MRI can improve diagnostic accuracy for prostate cancer patients and help avoid unnecessary biopsies, according to new research published in the April issue of&nbsp;<em>The Journal of Nuclear Medicine</em>. By applying the PRIMARY scoring system to PET/MRI results, researchers found that more than 80 percent of unnecessary biopsies could be avoided at the expense of missing one in eight clinically significant prostate cancer cases.